NCT07583563 An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
| NCT ID | NCT07583563 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Camurus AB |
| Condition | Acromegaly |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-06-05 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2026-06-05 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
Eligibility Criteria
Inclusion Criteria: * Have started or will be starting treatment with octreotide SC depot for acromegaly Exclusion Criteria: * Have started or will be starting treatment with octreotide SC depot for other conditions not related to acromegaly * Currently taking part in an interventional clinical trial or is still within a 30-day washout period from the end of taking part in an interventional clinical trial.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07583563 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acromegaly. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07583563 currently recruiting?
Yes, NCT07583563 is actively recruiting participants. Contact the research team at medicalinfo@camurus.com for enrollment information.
Where is the NCT07583563 trial being conducted?
This trial is being conducted at Aachen, Germany, Leipzig, Germany, Magdeburg, Germany, München, Germany and 1 additional location.
Who is sponsoring the NCT07583563 clinical trial?
NCT07583563 is sponsored by Camurus AB. The trial plans to enroll 200 participants.